Literature DB >> 17897338

Twin studies used to prove that the comorbidity of major depressive disorder with IBS is NOT influenced by heredity.

William E Whitehead.   

Abstract

Twin studies have traditionally been used to assess the heritability of diseases such as irritable bowel syndrome (IBS) by comparing concordance rates in monozygotic twins (identical genetic endowment) to dizygotic twins (half of genes shared). Wojczynski et al. used twins in a novel way-they studied monozygotic twins who were discordant for IBS (but who shared identical genes) to show that the comorbidity of IBS with major depressive disorder could NOT be due to genetic influences. This paradigm provides the most rigorous method for separating genetic from environmental influences and should be adopted by other researchers. However, the authors' conclusion that major depressive disorder and IBS are part of the same pathophysiological process is questioned on the basis of (a) incomplete co-occurrence of IBS and major depressive disorder (13-45% co-occurrence) and (b) lack of specificity-the authors show that chronic widespread pain (related to fibromyalgia) and chronic fatigue are also strongly associated with IBS. This study provides precise, generalizable estimates from a large population-based study for the comorbidity of IBS with major depressive disorder, chronic widespread pain, and chronic fatigue.

Entities:  

Mesh:

Year:  2007        PMID: 17897338     DOI: 10.1111/j.1572-0241.2007.01472.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Is the DHEAS/cortisol ratio a potential filter for non-operable constipated cases?

Authors:  A M El-Tawil
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 2.  Genetic determination of irritable bowel syndrome.

Authors:  Cristina Hotoleanu; Radu Popp; Adrian-Pavel Trifa; Laurentiu Nedelcu; Dan-L Dumitrascu
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 3.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.